Research News for 2012
-
Art Therapy and Meditation Can Ease Stress in Women Diagnosed with Breast Cancer
A small study found that art therapy combined with meditation helped ease stress in women diagnosed with breast cancer.
-
Dose-Dense Ellence Regimen Better for High-Risk Breast Cancer Than Early-Stage Breast Cancer
Two studies looking at a dose-dense regimen of Ellence compared to a standard schedule found that the dose-dense regimen is better for high-risk breast cancer.
-
Femara Better Than Tamoxifen for Certain Types of Breast Cancer
Femara was better than tamoxifen in treating postmenopausal women diagnosed with estrogen-receptor-positive, HER2-negative, lobular breast cancer; it was also better at treating luminal B breast cancers.
-
Study Finds Physical Evidence That Chemo Brain is Real
A study found that chemo brain is associated with changes in the way parts of the brain use glucose.
-
Experimental Medicine Seems to Help Treat Estrogen-Receptor-Positive, HER2-Negative, Advanced-Stage Breast Cancer
An early study suggests that an experimental medicine given in combination with Femara offers more benefits in treating advanced-stage, estrogen-receptor-positive, HER2-negative breast cancer than Femara alone.
-
Higher Faslodex Dose Better for Recurrent or Metastatic Breast Cancer
A study has found that women diagnosed with recurrent or metastatic, hormone-receptor-positive breast cancer lived longer when they got 500 mg of Faslodex compared to women who got 250 mg of Faslodex.
-
New Studies Show Avastin Provides Little Benefit for Breast Cancer
More research shows that Avastin offers few benefits in treating breast cancer.
-
Chemotherapy Slightly Ups Risk of Leukemia
Chemotherapy slightly increases the risk of leukemia later in life.
-
African American Women Less Likely to Have Sentinel Node Surgery
Research suggests that African American women are about 33% less likely than white women to have sentinel lymph node dissection; this difference was linked to a much higher risk of lymphedema risk in African American women.
-
Triple-Negative Breast Cancer Seems to Have Abnormal Genes That May Be Treatment Targets
A small study has found that many triple-negative breast cancers have abnormal genes that could be targeted by medicines already on the market or being developed.
